comprehensive
Previous article:
Alkermes shareholders re
Next article: Medicare explains how it will choose drugs for negotiation
Next article: Medicare explains how it will choose drugs for negotiation
focus
leisure time
-
Setback for rare diseases as Taysha Gene Therapies pulls back
2025-09-29 01:04 -
How a symptom of dementia informs our understanding of creativity
2025-09-29 00:53 -
CDC picks Alphabet's Verily for wasterwater surveillance contract
2025-09-29 00:53 -
Nobel honors Karikó and Weissman's enduring partnership
2025-09-29 00:52 -
The Karikó problem: Lessons for funding basic research
2025-09-29 00:42 -
The stability of $0 premiums in Medicare Advantage
2025-09-28 22:37